Knoll Capital Management as of March 31, 2023
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 25 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aldeyra Therapeutics (ALDX) | 31.5 | $21M | 2.1M | 9.93 | |
| Biohaven Pharmaceutical Holding | 9.5 | $6.2M | 450k | 13.66 | |
| Avadel Pharmaceuticals Sponsored Adr Call Option (AVDL) | 7.0 | $4.6M | 500k | 9.16 | |
| Verona Pharma Sponsored Ads (VRNA) | 6.2 | $4.0M | 200k | 20.08 | |
| Vaneck Gold Miners ETF Gold Miners ETF (GDX) | 4.6 | $3.0M | 92k | 32.35 | |
| Entera Bio SHS (ENTX) | 4.4 | $2.9M | 2.5M | 1.16 | |
| Applied Therapeutics (APLT) | 4.3 | $2.8M | 3.5M | 0.81 | |
| Global X Silver Miners ETF 37954Y848 Global X Silver (SIL) | 4.2 | $2.8M | 90k | 30.72 | |
| Ocular Therapeutix (OCUL) | 3.4 | $2.2M | 296k | 7.52 | |
| Vaneck Junior Gold Miners ETF Junior Hold Mine (GDXJ) | 3.2 | $2.1M | 53k | 39.50 | |
| Osisko Gold Royalties (OR) | 2.0 | $1.3M | 400k | 3.18 | |
| Thermo Fisher Scientific (TMO) | 1.9 | $1.2M | 2.1k | 578.00 | |
| Booz Allen Hamilton HLDG COR Cl A (BAH) | 1.9 | $1.2M | 13k | 92.69 | |
| Visa Com Cl A (V) | 1.7 | $1.1M | 4.9k | 225.46 | |
| CVS Caremark Corporation (CVS) | 1.7 | $1.1M | 15k | 74.31 | |
| Silvercrest Metals (SILV) | 1.6 | $1.0M | 170k | 6.14 | |
| Omega Therapeutics (OMGA) | 1.6 | $1.0M | 173k | 6.03 | |
| Seabridge Gold (SA) | 1.6 | $1.0M | 80k | 12.95 | |
| Franco-Nevada Corporation (FNV) | 1.6 | $1.0M | 7.0k | 145.80 | |
| Altria (MO) | 1.6 | $1.0M | 23k | 44.62 | |
| Northrop Grumman Corporation (NOC) | 1.5 | $1000k | 2.2k | 461.72 | |
| Orgenesis | 1.2 | $749k | 635k | 1.18 | |
| Altimmune Com New (ALT) | 1.1 | $734k | 174k | 4.22 | |
| Ocuphire Pharma (OCUP) | 0.6 | $375k | 100k | 3.75 | |
| Hookipa Pharma Inc equity (HOOK) | 0.3 | $221k | 300k | 0.74 |
